US Patent Issued to ModernaTX on Oct. 27 for "Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,310, issued on Oct. 27, was assigned to ModernaTX Inc. (Cambridge, Mass.).

"Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis" was invented by Jean C. Sung (Cambridge, Mass.), David Reid (Medford, Mass.), Alicia Anne Bicknell (Somerville, Mass.), Ana Cadete Pires (Arlington, Mass.) and Jeffrey Hrkach (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to delivery vehicles comprising payload molecules, e.g., mRNA or gene editing therapeutics for the treatment of cystic fibrosis (CF). Nucleic acid therapeutics (e.g., mRNAs) for use in the invention, wh...